71 related articles for article (PubMed ID: 17461006)
1. Benchmarking epidemiological characteristics of cervical cancer in advance of change in screening practice and commencement of vaccination.
Luke C; Nguyen AM; Heard A; Kenny B; Shorne L; Roder D
Aust N Z J Public Health; 2007 Apr; 31(2):149-54. PubMed ID: 17461006
[TBL] [Abstract][Full Text] [Related]
2. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
Roder D; Webster F; Zorbas H; Sinclair S
Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
[TBL] [Abstract][Full Text] [Related]
3. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
4. The value of local registry data for describing cervical cancer management and outcomes over three decades in Australia.
Roder D; Davy M; Selva-Nayagam S; Gowda R; Paramasivam S; Adams J; Keefe D; Eckert M; Powell K; Fusco K; Buranyi-Trevarton D; Oehler MK
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28929537
[TBL] [Abstract][Full Text] [Related]
5. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
6. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
Taylor R; Morrell S; Mamoon H; Wain G; Ross J
Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
[TBL] [Abstract][Full Text] [Related]
7. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer epidemiology and survival in an Australian population.
Luke C; Price T; Karapetis C; Singhal N; Roder D
Asian Pac J Cancer Prev; 2009; 10(3):369-74. PubMed ID: 19640175
[TBL] [Abstract][Full Text] [Related]
9. Marrying research, clinical practice and cervical screening in Australian Aboriginal women in western New South Wales, Australia.
Read CM; Bateson DJ
Rural Remote Health; 2009; 9(2):1117. PubMed ID: 19459723
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
11. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
Luke C; Koczwara B; Karapetis C; Pittman K; Price T; Kotasek D; Beckmann K; Brown MP; Roder D
Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
[TBL] [Abstract][Full Text] [Related]
12. Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia.
Hall MT; Simms KT; Lew JB; Smith MA; Saville M; Canfell K
PLoS One; 2018; 13(2):e0185332. PubMed ID: 29444073
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
14. History, development and future of cancer screening in Australia.
Olver IN; Roder D
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
[TBL] [Abstract][Full Text] [Related]
15. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
Luke C; Priest K; Roder D
Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
[TBL] [Abstract][Full Text] [Related]
16. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
[TBL] [Abstract][Full Text] [Related]
17. Exploring trends in laryngeal cancer incidence, mortality and survival: implications for research and cancer control.
Luke CG; Yeoh E; Roder DM
Asian Pac J Cancer Prev; 2008; 9(3):397-402. PubMed ID: 18990009
[TBL] [Abstract][Full Text] [Related]
18. Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994).
Walker JJ; Brewster D; Gould A; Raab GM
Public Health; 1998 Nov; 112(6):373-8. PubMed ID: 9883033
[TBL] [Abstract][Full Text] [Related]
19. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.
Mathew A; George PS
Asian Pac J Cancer Prev; 2009; 10(4):645-50. PubMed ID: 19827887
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer in the human papillomavirus vaccination era.
Tay SK
Curr Opin Obstet Gynecol; 2012 Feb; 24(1):3-7. PubMed ID: 22123221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
